Fujian Shengdi Pharmaceutical
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (61)
A Phase III Study To Evaluate the Efficacy And Safety Of HRS9531 In Participants With Atherosclerotic Cardiovascular Disease
Started: 5/29/2026
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Started: 8/13/2025
Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin
Started: 7/25/2025
A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity
Started: 7/25/2025
Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Started: 7/17/2026
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
Started: 7/24/2026
A Study Comparing the Efficacy and Safety of HRS9531 Injection With Semaglutide Injection in Subjects With Obesity
Started: 12/25/2025
HR20013 for Nausea and Vomiting Associated With Moderate Emetic Risk Anticancer Agents
Started: 9/3/2024
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
Started: 5/13/2024
A Study of HRS9531 Versus Semaglutide Once Weekly as Add-on Therapy to Metformin Monotherapy or in Combination With SGLT2 Inhibitors in Participants With Type 2 Diabetes
Started: 10/31/2024
the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone
Started: 11/8/2024
Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
Started: 9/21/2022
A Trial of Ribupatide Injection in Participants With Obesity and Knee Osteoarthritis
Started: 7/1/2026
Phase II Clinical Study of HRS-9057 Injection in Patients With Heart Failure-induced Fluid Retention
Started: 12/31/2025
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
Started: 6/6/2024
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
Started: 7/14/2026
A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis
Started: 8/14/2026
A Clinical Trial of HRS5580 for Injection Combined With Palonosetron Hydrochloride for the Prevention of Postoperative Nausea and Vomiting
Started: 8/6/2026
Efficacy and Safety of HRS9531 Tablet in Obese Subjects
Started: 4/7/2025
A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events
Started: 10/21/2025
Phase II Clinical Trial Evaluating the Efficacy and Safety of HRS-7249 and SHR-1918 in Patients With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis
Started: 2/25/2026
Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension
Started: 1/14/2026
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
Started: 5/6/2024
HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.
Started: 10/31/2025
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
Started: 8/12/2025
Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects
Started: 8/12/2023
Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
Started: 6/13/2023
A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
Started: 6/25/2024
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
Started: 4/27/2024
A Multicenter, Randomized, Double-blind, Placebo-parallel-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of HRS9531 Injection in Obese Subjects With Polycystic Ovary Syndrome
Started: 9/1/2024
A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea
Started: 8/1/2024
A Study of Remimazolam Tosilate for Sedation in the ICU
Started: 10/12/2022
Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects
Started: 10/16/2023
A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity
Started: 7/1/2026
A Extension Study to Evaluate the Safety and Efficacy of HRS-7249 in Patients With Hypertriglyceridemia
Started: 9/30/2026
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity
Started: 6/12/2026
A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function
Started: 5/26/2026
Relative Bioavailability of First vs Second-Generation Formulations of HRS9531 Tablets in Obese or Overweight Subjects
Started: 10/15/2025
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-5817 Injection
Started: 5/8/2025
A Single Ascending Dose of HRS-2162 in Healthy Subjects
Started: 9/25/2025
A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects
Started: 2/28/2024
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-4729 Injection in Healthy Subjects
Started: 1/16/2025
A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects
Started: 12/2/2024
A Study of HRS-9057 in Patients With Heart Failure and Volume Overload
Started: 8/16/2024
Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial
Started: 8/6/2024
A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects
Started: 8/15/2024
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Subcutaneous Injection of HRS-9563 in Subjects With Mild Hypertension: a Randomized, Double-blind, Placebo-controlled Phase I Study.
Started: 12/24/2024
Mass Balance Study of [14C]HRS9531 in Healthy Male Subjects
Started: 4/21/2025
Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects
Started: 12/18/2024
The Evaluation of Bioequivalence Between a Single-dose Pen and a Multi-dose Pen of HRS9531 Injection Solution
Started: 2/11/2025
A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects
Started: 6/4/2024
Influence of HRS9531 on Pharmacokinetics of Metformin in Healthy Subjects
Started: 11/5/2024
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
Started: 10/12/2022
A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants
Started: 7/1/2026
A Relative Bioavailability Study of HRS9531 in Healthy Subjects
Started: 5/15/2023
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS3797 in Healthy Subjects
Started: 2/15/2023
Study of HR20013 for Injection in Patients With Malignant Solid Tumors
Started: 8/30/2022
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy Subjects
Started: 12/6/2021
A Mass Balance Study of [14C]HRS-9057 for Injection in Healthy Participants
Started: 8/11/2026
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants
Started: 9/1/2026
A Single-Dose Pharmacokinetic Study of HRS-4729 Injection in Healthy Participants and Patients With Renal Impairment
Started: 9/1/2026